Why AI is lacking in the field of CDM?

Artificial intelligence (AI) has great potential to identify eligible patients for clinical trials. However, the reality is quite different from expectations. The major problem has been the development of sophisticated algorithms. Other barriers include the unstructured format of data and how to integrate that data into the clinical workflow of stakeholders.

Leave a Reply

Your email address will not be published. Required fields are marked *